Infection of ruminants by Fasciola spp continues to cause large Econom
ic losses worldwide. Recent results from several laboratories have dem
onstrated that animals can be significantly protected against infectio
n by vaccination with defined Fasciola antigens. Apart from reducing f
luke burdens, some vaccines can elicit a concurrent reduction in paras
ite egg production. The expectation of a commercially feasible vaccine
that might also reduce parasite transmission in the field is now real
istic, although major hurdles still exist. Here, Terry Spithill and Jo
hn Dalton review the results of several recent vaccine trials and disc
uss the future prospects for vaccine development.